(Q34424777)

2 August 2017

1 reference

title

Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis. (English)

1 reference

2 August 2017

L Breen

1

1 reference

2 August 2017

N Aswani

series ordinal

2

1 reference

2 August 2017

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

2 August 2017

published in

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

CD002767

1 reference

The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Single versus combination intravenous antibiotic therapy for people with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

The changing epidemiology of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002767

10.1002/14651858.CD002767

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference